|
Richmond Pharmacology - exhibitor
|
|
 Richmond Pharmacology provides an integrated solution to your Early Phase Requirements.
Founded in 2001, Richmond Pharmacology has grown to become the UK’s largest Early Phase full-service CRO. The team at Richmond Pharmacology provide the pharmaceutical industry with the design, conduct and management of Early Phase studies to the highest clinical standard. Our two Trial Centres, both based in acute hospitals provide direct on-site access to emergency facilities. Our founding Directors, all experienced Clinical Pharmacologists and Trialists, work alongside our Scientific Advisory Board to provide a very dedicated team of professionals across a range of studies during Early Phase clinical development.
Our experience includes Phase I, Phase II and combined Phase I/II protocols. These are conducted within our two dedicated Trial Centres housing both in-patient and out-patient facilities and together provide a combined capacity of 100 beds. As well as our focus on the first administration of compounds into Man, our unique hospital surroundings provides on site access to consultants across an unrivalled range of therapeutic areas, their involvement extending to both study design input and patient recruitment.
Key Features:
- 2 Integrated Early Phase hospital based Trial Centres – 100 beds
- Unrivalled Therapeutic Expertise
- Over 80,000 registered volunteers
- Direct access to various patient populations
- Extensive Phase I and Phase II Study Experience
- Experts in the conduct of QTc Studies in alliance with Cardiologist, Professor A.J.Camm
www.richmondpharmacology.com
|
|
Phase One Trials - exhibitor
|
|
 PhaseOneTrials is an independent CRO specialising in conduct of phase I and phase IIa clinical trials performed under the strictest safety and quality standards. We operate our own restricted-access 36 bed trial unit at Hvidovre University Hospital and have immediate and unique access to patients and exceptional medical competencies in an environment that always puts clinical excellence and safety first.
First-in-Man trials – We have extensive experience in 'First-in-Man' trials with small molecule as well as biological drug compounds. With immediate access to the hospital’s intensive care unit, and having close collaboration with recognised medical specialists, PhaseOneTrials easily meet the increasingly stringent safety requirements for First-in-Man trials.
Proof-of-Concept trials – We have conducted numerous 'Proof-of-Concept' trials for international pharmaceutical and biotech companies. We have the access to efficient medical expertise, access to specified patient populations, and the dedication to meet our clients' expectations in this field.
Our services - We specialise in the clinical aspects of the trial - providing our clients with the most accurate and reliable data related to the safety and/or efficacy of the study drug. Together with a select group of specialised partners we offer a complete range of services e.g. protocol writing, CRF design, data management and biostatistics and consultancy.
Healthy volunteers and patient populations – We maintain an up-to-date database of knowledgeable and social competent pre-qualified healthy volunteers. Through our own databases or via co-operation with specialist hospital departments, we have access to a variety of patient populations, including patients with: psoriasis, osteoporosis, diabetes, impaired liver function and chronic hepatitis C, asthma, COPD, HIV and children’s disease.
www.phaseonetrials.com
|
|
Biotrial - exhibitor
|
|
 Biotrial is an independent CRO offering a large range of services to the biotech and pharmaceutical industry: Phase I studies (including special populations), Imaging and ECG Central Lab, Clinical Trial Management, Data Management, Bio-Statistics, Medical Writing & Non-Clinical (including Safety) Pharmacology. With over 80 Phase I studies/year, Biotrial, a leading service provider in early development in Europe, is the ideal Full-Service CRO partner for studies from Non-Clinical to Phase III.
In addition, Biotrial’s ECG Central Lab successfully manages multiple studies each year. Both single-site Phase I set trials and international, multicenter trials can be managed by our experienced team of experts, cardiologists, project managers and data managers.
Being a Full-Service CRO offering both Clinical Services - 150 beds in different Phase I units, a database of nearly 30,000 volunteers - and ECG Central Services, Biotrial is your ideal partner for designing and conducting TQT studies following the ICH E14 guideline.
www.biotrial.com
|
|
SGS - sponsor
|
|
 SGS’ Life Science Services, part of the SGS group (50.000 employees) has 30 years of experience as a global contract service organization providing integrated solutions from preclinical activities to Phase I-IV trials, bioanalytical and QC testing. With more than 1,300 employees and 2,000 clinical trials performed, SGS serves the pharmaceutical, biotechnology and medical device industries.
SGS’ state of the art facilities include: two Phase I units with a total of 162 beds, three bioanalytical labs, and a network of Phase II-IV clinical trial management offices throughout Europe, North America and Asia. Through years of executing complex clinical trials SGS has a wealth of expertise in:
- Exploratory and pharmacology trials: FIH trials, intricate designs, QT/QTc prolongation, C14 ADME & PET scan and POC trials
- Clinical Trial Management including:
-Special populations: pediatric, renal & hepatic impaired, postmenopausal and sterilized women, elderly and slow metabolizer patients
-Numerous therapeutic areas with a particular focus on: Infectious diseases, including HIV, hepatitis and vaccines, Cardiac diseases and coagulation, Neurological diseases and Respiratory diseases
SGS offers also extensive:
- Bioanalytical capabilities featuring mass spectrometry and immunoanalysis
- Biometrics team support Phase I-IV clinical trials, experts in working in: Oracle Clinical® & ClinTrial®, CDISC & EDC
- Regulatory Affairs and Pharmacovigilance services with a full support services from pre-clinical to post-marketing including regulatory monitoring of the IMP and SAE / ADR handling
With innovative study designs, optimal facilities and strong regulatory intelligence, SGS can favorably impact client’s drug development timelines and decision-making process.
www.sgs.com/CRO
|
|
|
|
|
|
Reserve an exhibition stand at the Safety Pharmacology World Europe exhibition - book early to ensure optimum stand placement!
| |
Reserve a stand
For details contact
James Hopkins
+44 207 608 7038 |
|
|
|
|
